Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Por um escritor misterioso
Descrição
Neoadjuvant and adjuvant treatment received by patients with mucosal
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Neoadjuvant Immunotherapy Expands Its Reach in Metastatic Melanoma
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy - Smithers - 2021 - ANZ Journal of Surgery - Wiley Online Library
Cancers, Free Full-Text
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Frontiers Adjuvant immunotherapy in early-stage resectable non–small cell lung cancer: A new milestone
